Cefepime for prophylaxis of infections in the surgery of cholelithiasis. Results of a multicentric comparative trial

Acta Biomedica de l'Ateneo Parmense

Volumn 79, Issue 1, 2008, Pages 23-27

  Del Rio, Paolo ^a,g   Vellone, Maria ^b   Fragapane, Paolo ^c   Di Millo, Marcello ^d   Mazzitelli, Riccardo ^e   Allegri, Carlo ^f   Nuzzo, Gennaro ^b   Sianesi, Mario ^a  

^a UNIVERSITY OF PARMA MEDICAL SCHOOL   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c MAURIZIANO HOSPITAL   (Italy)

^d UNIVERSITY OF FOGGIA   (Italy)

^e Department of General Surgery   (Italy)

^f Cristo Re Hospital   (Italy)

^g UNIVERSITY OF PARMA   (Italy)

Author keywords

Antimicrobial prophylaxis; Biliary tract surgery; Cefepime; Ceftriaxone; Cholecystectomy

Indexed keywords

ANTIBIOTIC AGENT; CEFEPIME; CEFTRIAXONE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BILIARY TRACT SURGERY; CHOLECYSTECTOMY; CHOLELITHIASIS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; HUMAN; INFECTION PREVENTION; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; MULTICENTER STUDY; OPEN STUDY; POSTOPERATIVE INFECTION; PREOPERATIVE CARE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; CEFTRIAXONE; CEPHALOSPORINS; CHOLELITHIASIS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 48749125740     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Rotzos I, Ferenczy J, Rozsos T. Antibiotic prophylaxis in cholecystectomy performed by micro- and minilaparotomy. Orv Hetil 1993; 134 (49): 2703-6.
2. Croce E, Azzola M, Golia M, et al. Laparocholecystectomy 6865 cases from Italian institutions. Surg Endosc 1994; 8 (9): 1088-91.
3. Seale AK, Ledet WP Jr. Minicholecystectomy: a safe, cost-effective day surgery procedure. Arch Surg 1999; 134 (3): 308-10.
4. Oyogoa SO, Komenaka IK., Ilkhani R, et al. Minilaparotomy cholecystectomy in the era of laparoscopic cholecystectomy: a community based hospital perspective. Am Surg 2003; 69 (7): 604-7.
5. Bingener J, Richards ML, Scwesinger WH, et al. Laparoscopic cholecystectomy for elderly patients:gold standard in golden year? Arch Surg 2003; 138 (5): 531-5.
6. Moran C, McNaught W, McCardle CS. Prophylactic cotrimoxazole in biliary surgery. BMJ 1978; 2: 462-4.
7. Brodgen RN, Ward A. Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration. Drugs 1988; 35 (6): 604-45.
8. Davis R, Bryson HM. Ceftriaxone. A pharmacoeconomic evaluation of its use in the treatment of serious infection. Pharmacoeconomics 1994; 6 (3): 249-69.
9. Lamb HM, Ormrod D, Scott LJ, et al. Ceftriaxone : an update of its use in the management of community acquired and nosocomial infections. Drugs 2002; 62 (7): 1041-89.
10. Yellin AE, Berne TV, Appleman MD, et al. A randomized study of Cefepime versus the combination of Gentamicin and Mezlocillin as an adjunct to surgical treatment in patients with acute cholecystitis. Surg Gynecol Obstet 1993; 177 Suppl: 23-9; discussion 35-40.
11. Thompson JE Jr, Bennion RS, Roettger R, et al. Cefepime for infections of the biliary tract. Surg Gynecol Obstet 1993; 177-Suppl: 30-4; discussion 35-40.
12. Biron P, Fuhrmann C, Cure H, Viens P, et al. Cefepime versus imipenem -cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in cancer). J Antimicrob Chemother 1998; 42 (4): 511-8.
13. Zervos M, Nelson M. Cefepime versus ceftriaxone for empiric treatment of hospitalized patients with community-acquired pneumonia. The cefepime Study Group. Antimicrob Agents Chemother 1998; 42 (4): 729-33.
14. Price KE, McGregor DN. Basic design of B-lactam antibiotics- cephalosporins. Scand J Infect Dis 1984; 42.
15. Culver DH, Horan TC, Gaynes RP, et al: Surgical wound infection rates by wound class, operative procedure and patient risk index: National Nosocomial Infections Surveillance System. Am J Med 1991 Sep 16; 91 (3B): 152S-157S.
16. Sianesi M, Ghirarduzzi A, Percudani M. Peroperative antibiotic therapy in biliary surgical diseases. Acta Biomed Ateneo Parmense 1982; 53 (3): 201-6.
17. Meijer WS, Schmitz PIM, Jeekel J. Meta-analysis of randomized controlled clinical trials of antibiotic prophylaxis in biliary tract surgery. Br J Surg 1990; 77: 283-90.
18. Targarona EM, Balaguè C, Knook M, et al. Laparoscopic surgery and surgical infection. Br J Surg 2000: 87: 536-44.
19. Catarci M, Mancini S, Gentileschi P, et al. Antibiotic prophylaxis in elective laparoscopic cholecystectomy: lack of need or lack of evidence? Surg Endosc 2004 Feb 2; 17(12).
20. Lippert H, Gastinger J. Antimicrobial prophylaxis in laparoscopic and conventional cholecystectomy. Conclusions of a large prospective multicenter quality assurance study in Germany. Chemotherapy 1998; 44 (5): 355-63.
21. Zanetti G, Bally F, Greub G, et al. Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia intensive care unit patients:a multicenter, evaluator blind, prospective, randomized study. Antimicrob Agents Chemother 2003; 47 (11): 3442-7.
22. Sanders CC, Sanders WE. Microbial resistance to newer generation b-lactam antibiotics: clinical and laboratory implications. J Infect Dis 1985; 151 (3): 399-406.
23. Neu HC. Beta-lactam antibiotics: structural relationship affecting in vitro activities and pharmacological properties. Rev Infect Dis 1986; 8 Suppl 3: S237-59.
24. Bellido F. Reevaluation of the factors involved in the efficacy of new Beta-lactams against Enterobacter cloacae. Antimicrob Agents Chemoter 1991; 35 (1): 73-8.
25. Sanders CC. Beta-lactamases of Gram-negative bacteria: new challenges for new drugs. Clin Infect Dis 1992; 14 (5): 1089-99.
26. Gialdroni Grassi G, Grassi C. Cefepime:overview of activity in vitro and in vivo. J Antimicrob Chemoter 1993; 32 Suppl B: 87-94.
27. Ehrardt AF, Sanders CC. Beta-lactam resistance amongst Enterobacter species. J Antimicrob Chemoter 1993; 32 Suppl B: 1-11.
28. Barradel LB, Bryson HM. Cefepime. A review of its antibacterial actvity, pharmacokinetic properties and therapeutic use. Drugs 1994; 47 (3): 471-505.
29. Paladino JA, Eubanks DA, Adelman MH, Schentag JJ. Once-daily cefepime versus ceftriaxone for nursing home-acquired pneumonia. J Am Geriatr Soc 2007; 55 (11): 651-7.